Osteogenic effects of D()Β-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats

Acta Pharmacologica Sinica

Volumn 30, Issue 3, 2009, Pages 321-332

  Cui, Liao ^a   Liu, Yu Yu ^a   Wu, Tie ^a   Ai, Chun Mei ^a   Chen, Huai Qing ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Adipocyte; D(+) 3,4 dihydroxyphenyl lactic acid (salvianic acid A); Glucocorticoid; Marrow stromal cell; Osteoblast; Osteogenesis; Rat

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; FAT DROPLET; LIPOPROTEIN LIPASE; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN; PREDNISONE; SALVIA MILTIORRHIZA EXTRACT; SALVIANIC ACID; SIMVASTATIN; UNCLASSIFIED DRUG; CAFFEIC ACID DERIVATIVE; GLUCOCORTICOID; HERBACEOUS AGENT; LACTIC ACID DERIVATIVE; PLANT EXTRACT; SALVIANOLIC ACID A;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CALVARIA; CELL CULTURE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DENSITY GRADIENT CENTRIFUGATION; DRUG STRUCTURE; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STROMA CELL; TREATMENT DURATION; ANIMAL; CELL DIFFERENTIATION; CELL SHAPE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; NEWBORN; PHYSIOLOGY; SALVIA; SPRAGUE DAWLEY RAT;

ALKALINE PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; CAFFEIC ACIDS; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; COLLAGEN TYPE I; DRUGS, CHINESE HERBAL; GLUCOCORTICOIDS; LACTATES; LIPOPROTEIN LIPASE; MALE; MOLECULAR STRUCTURE; OSTEOCALCIN; OSTEOGENESIS; PLANT EXTRACTS; PREDNISONE; RATS; RATS, SPRAGUE-DAWLEY; SALVIA; STROMAL CELLS;

EID: 64849111963     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.9     Document Type: Article

References (39)

1. Canalis E. Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 2005; 3: 98-102.
2. Delany AM, Durant D, Canalis E. Glucocorticoid suppression of IGF-I transcription in osteoblasts. Mol Endocrinol 2001; 15: 1781-9.
3. Walsh S, Jordan GR, Jefferiss C, Stewart K, Beresford JN. High concentrations of dexamethasone suppress the proliferation but not difFerentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology 2001; 40: 74-83.
4. Sher LB, Harrison JR, Adams DJ, Kream BE. Impaired cortical-bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif Tissue Int 2006; 79: 118-25.
5. Ito S, Suzuki N, Kato S, Takahashi T, Takagi M. Glucocorticoids induce the difFerentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast difFerentiation. Bone 2007; 40: 84-92.
6. Nuttall ME, Gimble JM. Controlling the balance between osteo-blastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004; 4: 290-4.
7. Ghen W, Dong YL, Wang GG, Ting GS. Pharmacological studies of sodium tanshinone II-A sulfonate. Yao Xue Xue Bao 1979; 14: 277-83.
8. Yasumasa I, Izumi M, Yutaka T. Abietane type diterpenoids from Salvia miltiorrhiza. Phytochemistry 1989; 28: 3139-41.
9. Hu P, Liang QL, Luo GA, Zhao ZZ, Jiang ZH. Multi-component HPLC fingerprinting of Radix Salviae Miltiorrhizae and its LC-MS-MS identification. Chem Pharm Bull 2005; 53: 677-83.
10. Zhou L, Chow M, Zuo Z. Improved quality control method for Danshen products-consideration of both hydrophilic and lipophilic active components. J Pharm Biomed Anal 2006; 41: 744-50.
11. Zhao BL,JingW, Zhao Y, Hou JW, Xin WJ. Scavenging effects of Salvia miltiorrhiza on free radical and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. BiochemMol Int 1996; 38: 1171-82.
12. TangMK, Ren DC, Zhang JT,DuGH. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002; 9: 405-9.
13. Lay IS, Chiu JH, Shiao MS, Lui WY, Wu CW. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angio-genesis in murine SVR endothelial cell line. Planta Med 2003; 69: 26-32.
14. Wang JG, Cao B. Progress of research on the promotion of bone union of fracture with Danshen. Chin J Orthop Traum 2003; 16: 637-8.
15. Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats. Acta Pharmacol Sin 2004; 25: 678-84.
16. Lee SY, Choi DY, Woo ER. Inhibition of osteoclast difFerentiation by tanshinones from the root of Salvia Miltiorrhiza Bunge. Arch Pharmacol Res 2005; 28: 909-13.
17. Cui L, Zhou LY, Liu YY, Ai CM, Wu T, Wu Y. Preventing cancellous bone loss in steroid-treated rats and stimulating bone formation by water extract of Salvia miltiorrhiza and Danshensu. Chin Pharmacol Bull 2004; 20: 286-91.
18. Kwak HB, Sun HM, Ha H, Kim HN, Lee JH, Kim HH, et al. "Ihanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts. Eur J Pharmacol 2008; 601: 30-7.
19. TangLY, KimmelDB,Jee WS, YeeJA. Functional characterization of prostaglandin e2 inducible osteogenic colony forming units in cultures of cells isolated from the neonatal rat calvarium. J Cell Physiol 1996; 166: 76-83.
20. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57-66.
21. Bernard GW. Ultrastructural localization of alkaline phosphatase in initial intramembranous osteogenesis. Clin Orthop Relat Res 1978; 135: 218-25.
22. Pittenger MF, Mackay AM, BeckSC,Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284 (5411): 143-7.
23. Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, et al. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Bone 2009; 44: 113-9.
24. Haguenauer D, Welch V, Shea B, Tugwell P, Wells G. Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev 2000; (4): CD002825.
25. Khosla S. Minireview: The OPG/R?NKL/R?NK system. Endocrinology 2001; 142:5050-5.
26. Hofbauer LC, Kühne CA, Viereck V. The OPG/R?NKL/R?NK system in metabolic bone diseases. J Musculoskelet Neuronal Interact 2004; 4: 268-75.
27. Hu MZ. Effect of radix slaviae miltiorrhizae on the mitotic activity of osteoblast-like cells isolated from chicken embryo calvariae cultured in vitro. ChinJ Surg 1993; 31: 251-3.
28. Liu YR, Qu SX, Maitz MF, Tan R, Weng J. The effect of the major components of Salvia miltiorrhiza Bunge on bone marrow cells. J Ethnopharmacol 2007; 111: 573-83.
29. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007; 18: 1319-28.
30. Li X, Cui Q, Kao C, Wang GJ, Balian G. Lovastatin inhibits adipo-genic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003; 33: 652-9.
31. Williams S, Barnes J, Wakisaka A, Ogasa H, Liang CT. Treatment of osteoporosis with MMP inhibitors. Ann N Y Acad Sci 1999; 878: 191-200.
32. Tang QO, Tran GT, Gamie Z, Graham S, Tsialogiannis E. Statins: under investigation for increasing bone mineral density and augmenting fracture healing. Expert Opin Investig Drugs 2008; 17: 1435-63.
33. Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL. Role of the cholesterol biosynthetic pathway in osteoblastic difFerentiation of marrow stromal cells. J Bone Miner Res 2002; 17: 1997-2003.
34. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2002; 17: 1135-40.
35. Astudillo P, Ríos S, Pastenes L, Pino AM, Rodriguez JP. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. J Cell Biochem 2008; 103: 1054-65.
36. Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, et al. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Miner Res 2006; 21: 565-75.
37. Kaback LA, Soung do Y, Naik A, Geneau G, Schwarz EM, Rosier RN, et al. Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem 2008; 105: 219-26.
38. +-induced cytotoxicity. Neurosci Res 2005; 51: 129-38.
39. Sun Y, Cui L, Wu T. Preparation of Salvia miltiorrhiza utility aqueous extract by hydrochloric acid method and evaluation on osteoblast. Chin Pharmacol Bull 2008; 24: 377-81.